Abstract During the last years remission rates of more than 72% for arsenic(III) (BSO). Other modulators of the cellular redox system showed this effect to a lower extent and enhancement was not consistent for the different cell lines tested. Caspase inhibitors protected cell lines from Sb 2 O 3 -and As 2 O 3 -induced apoptosis. When BSO was added, the inhibitors lost their protective ability. The ability of modulators of the cellular redox system in clinically applicable concentrations to enhance the apoptotic effects of the two oxides in a synergistic way may be helpful to reduce their toxicity by optimizing their dose.
Introduction
During the last 10 years, several groups demonstrated remission of more than 72% for arsenic(III)-oxide (As 2 O 3 ) treatment in relapsed or refractory acute promyelocytic leukemia (APL), as presented in various reviews [1] [2] [3] [4] [5] . As 2 O 3 was established as a potent alternative in therapy of all-trans retinoic acid (ATRA)-resistant APL and shows, like Sb 2 O 3 , similar cellular effects to ATRA in APL: localization of the t(15;17) specific PML-RARα-fusion protein in nuclear bodies and degradation of the fusion protein [6] [7] [8] [9] and induction of differentiation and apoptosis [10] [11] [12] [13] [14] . Lately, we showed that induction of apoptosis by As 2 O 3 in 22 myeloid and non-myeloid malignant cell lines of different sensitivity for cytostatic drugs, is based on breakdown of the mitochondrial membrane potential (Ψ m ) and therefore the redox system of the cell is one of the primary targets of As 2 O 3 . Activation of caspases is a downstream effect occurring after the breakdown of Ψ m [15] [16] [17] and release of radical oxygen species (ROS) [18] [19] [20] [21] .
Both antimony and arsenic are members of the Vth group of the table of elements and share common chemical characteristics. Based on the affinity of As 2 O 3 and Sb 2 O 3 we analyzed whether Sb 2 O 3 shows similar efficacy and identical mechanisms of action by investigation of the effects of Sb 2 O 3 on representative myeloid cell lines of different sensitivity groups for As 2 O 3 as classified in our previous report [22] . Given the increasing clinical use of As 2 O 3 , we were, in particular, interested in combinations that might be transferable to clinical application. Inhibitors of the cellular glutathione system were used to modulate the efficacy of As 2 O 3 and Sb 2 O 3 to induce apoptosis. The modulators analyzed in this report include the γ-glutamylcystein synthetase inhibitor DL-buthionine-[S,R]-sulfoximine (BSO), the glutathione peroxidase (GPx) inhibitor mercaptosuccinic acid (MS), as well as sodium ascorbate (NaAsc), sodium salicylate (NaSal), and 3-amino-1,2,4-azole (AT). Ascorbate was shown to decrease in glutathione-deficient rats and ascorbate spares glutathione and protects [23] , NaSal potentates the toxicity of BSO in the E47 cells [24] and AT inhibits catalase in the presence of H 2 O 2 and inhibits cyclizations leading to β-carotene and Φ-carotene accumulates. As far as data were achievable and tolerable concentrations of the different substances in vivo were available (BSO, NaAsc, NaSal), we have chosen concentrations within this range. For As 2 O 3 and Sb 2 O 3 we have chosen incubation times and concentrations as we previously published for As 2 O 3 [15, 17, 22] . The As 2 O 3 concentrations are in the range of peak values of clinically achievable As 2 O 3 plasma levels as shown by pharmacokinetic analysis [10] .
Materials and methods

Cell culture
Cell lines CCRF-CEM, HL-60, K-562, and LOUCY were purchased from The German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany), CEM/C1, CEM/C2, HL-60/MX1, and HL-60/MX2 from the American Type Culture Collection (Manassas, USA). The doxorubicin resistant cell lines K-562(0.02) and K-562 (0.1) were described previously [22] . Stock solutions of 10 mM of (S)-(+)-camptothecin (SIG-MA, Deisenhofen, Germany) in dimethyl sulfoxide (Sigma, Deisenhofen, Germany), 10 mM mitoxantrone hydrochloride (SIGMA, Deisenhofen, Germany) and 1 mg/mL doxorubicin hydrochloride (SIGMA, Deisenhofen, Germany) in 70 % ethanol (Carl ROTH GmbH, Karlsruhe, Germany) were used for further dilutions. Cells were seeded according to their optimal growth condition indicated by the provider.
Annexin V-FITC-and 7-AAD-staining As described previously [22] , the percentage of apoptotic cells was determined by two-color flow cytometry using an Annexin V-FITC (BD Pharmingen, Heidelberg, Germany) and 7-amino-actinomycin D (7-AAD) system (Sigma, Deisenhofen, Germany). Whenever possible, fluorescence data of 50.000 cells was acquired using fluorescence channels FL-1 and FL-3 of a FACScan (Becton Dickinson, Heidelberg, Germany). All experiments presented were performed three times, with the exception of those presented in Figs. 1, 5, and 6. In general, flow cytometry analysis was performed until the percentage of apoptotic cells was higher than 90% and acquisition of data was preformed for two further time points.
MitoTrackerRed CMXRos staining
MitoTrackerRed CMXRos (Molecular Probes, Leiden, The Netherlands) is a fluorescent dye that is enriched in mitochondria in a membrane potential dependent manner and reacts with mitochondrial proteins [25, 26] . Therefore, MitoTrackerRed CMXRos, can be used to detect cells with a loss of Ψ m [27, 28] . The CMX group binds to SH groups of mitochondrial proteins and is retained in living cells, while unbound dye can be washed out of the cells. Staining was performed as described in a previous report in 1 mL cell suspension (ca. 5×10 5 [15] . In order to compare the percentage of Incubation with modulators of the cellular GSH-redox system Fresh stock solutions of 100 mM DL-buthionine-[S,R]-sulfoximine (Sigma, Deisenhofen, Germany), 500 mM sodium salicylate (Sigma, Deisenhofen, Germany), 500 mM sodium ascorbate (Sigma, Deisenhofen, Germany), 100 mM mercaptosuccinic acid (Sigma, Deisenhofen, Germany) and 20 mM 3-amino-1,2,4-azole (Sigma, Deisenhofen, Germany) were prepared in PBS without Ca 2+ /Mg 2+ for each assay. All modulators of GSH were added together with PBS or the inducers of apoptosis (Sb 2 O 3 and As 2 O 3 ), when indicated. As we demonstrated in a recent report [22] atives CEM/C1 and CEM/C2 [22] . This prompted the question whether also Sb 2 O 3 can induce apoptosis in these two cell lines with multiple drug resistance [31, 32] [22] , no prolonged incubation time was necessary to induce apoptosis with increasing resistance to camptothecin for Sb 2 O 3 . Again, there was a high correlation between both methods used for the detection of apoptotic cells, Annexin V-FITC-and 7-AAD-staining: correlation coefficients were 0.973 for CCRF-CEM, 0.974
The HL-60 mitoxantrone resistant derivatives HL-60/ MX1 and HL-60/MX2 and the K-562 doxorubicin resistant derivatives K-562(0.02) and K-562(0.1) were insensitive to 1 µM Sb 2 O 3 and 5 µM Sb 2 O 3 (data not shown). As previously shown, these derivatives show reduced sensitivity to 1 µM As 2 O 3 and 5 µM As 2 O 3 as compared to their corresponding parental cell lines [22] .
Increased sensitivity towards Sb 2 O 3 -and As 2 O 3 -induced apoptosis by modulators of the cellular GSH-system
We addressed the potential role of the glutathione redox system for Sb 2 O 3 -and As 2 O 3 -mediated apoptosis: cell lines LOUCY (Fig. 3) , CCRF-CEM (Fig. 4) , HL-60 ( Fig. 5 ) and K-562 (Fig. 6) were treated with different substances known to influence Ψ m or to modulate or inhibit the synthesis of glutathione.
Therefore, we incubated the indicated cell lines for 7 days (LOUCY) or 14 days (CCRF-CEM, HL-60, K-562) with (Figs. 3a, 4a, 5a, 6a (Figs. 3d, 4d, 5d, 6d ) alone or together with sodium salicylate (NaSal, 500 µM for LOUCY, CCRF-CEM and K-562, 1 mM for HL-60), sodium ascorbate (NaAsc, 500 µM for LOUCY, CCRF-CEM and K-562, 1 mM for HL-60), DL-buthionine-[S, R]-sulfoximine (BSO, 100 µM for all cell lines), mercaptosuccinic acid (MS, 100 µM for all cell lines) or 3-amino-1,2,4-azole (AT, 20 mM for all cell lines). The percentages of 7-AAD-and Annexin V-FITC (data not shown)-positive cells were determined before incubation and after 1, 2, 4, 7, 10, and 14 days. None of the modulators or inhibitors alone triggered apoptosis, with the exception of MS for cell lines LOUCY and HL-60 and NaAsc for cell line K-562, where an increase of the apoptotic population could be observed.
In general, strong enhancement of the two oxides Sb 2 0 3 (1 µM and 5 µM) and As 2 O 3 (1 µM) by the inhibitor of the g-glutamylcystein synthetase BSO could be seen. Even when Sb 2 O 3 or As 2 O 3 were used in concentrations that were not or only weak effective by themselves (1 µM Sb 2 O 3 for LOUCY, CCRF-CEM and HL-60; 5 µM Sb 2 O 3 for K-562; 1 µM As 2 O 3 for CCRF-CEM and HL-60, 5 µM As 2 O 3 for K-562), an increase up to 100% of apoptotic cells was observed when 100 µM BSO were added to the assay. This phenomenon was consistently seen with all analyzed cell lines and was in particular remarkable with the cell line K-562 that was insensitive for Sb 2 O 3 -concentrations even higher than 5 µM (up to 10 µM, data not shown). Other modulators were less effective and did not demonstrate consistent synergistic results in all cell lines: NaAsc (250 or 500 µM) also induced slight increase in CCRF-CEM and K-562. In CCRF-CEM a synergistic effect was seen with 500 µM NaAsc and 1 µM Sb 2 O 3 which both were insensitive as single agents. Prolonged incubation with MS (100 µM) did enhance As 2 O 3 -and Sb 2 O 3 -induced apoptosis in HL-60 and K-562, but not in CCRF-CEM. Both AT and NaSal did not show consistent effects with the inductors of apoptosis in the different cell lines.
A high correlation of Annexin V-FITC and 7-AADstaining could be demonstrated for all assays: correlation coefficients were 0.993 for LOUCY, 0.956 for CCRF-CEM, 0.913 for HL-60, 0.885 for K-562, respectively. (Fig. 7) .
Pre-incubation was performed with three different caspase inhibitors for 1 h prior to (apoptosis) induction with Sb 2 O 3 (5 and 10 µM) or As 2 
Discussion
We were interested in magnifying the efficacy of As 2 O 3 using substances that might be transferable to clinical application because the clinical applications of As 2 O 3 gain in importance not only for therapy of relapsed and refractory APL [29, 30, [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] , but also for treatment of multiple myeloma [48] [49] [50] , myelodysplastic syndromes [51] [52] [53] , and renal cancer [54] . Recently, two reports described apoptosis induction, caspase activation and ROS production by very high concentrations (up to 40 µM) of potassium antimonyl tartrate in lymphoid tumor cell lines [55] and growth inhibition and induction of apoptosis and reactive oxygen species [56] . Due to the chemical affinity of Sb 2 O 3 and As 2 O 3 , we expected the same mechanism of apoptosis induction for the two substances. We observed Sb 2 O 3 -induced apoptosis in different myeloid and lymphatic cell lines (CCRF-CEM, HL-60, K-562), among them cell lines with reduced sensitivity to cytostatic agents (LOUCY, CEM/C1, CEM/C2). We were able to block Sb 2 O 3 -induced apoptosis by caspase inhibitors and, as presented previously for As 2 O 3 [15] , caspase-independent decrease of Ψ m . We therefore postulate a common mechanism for Sb 2 O 3 and As 2 O 3 mediated apoptosis. However, based on the same molar concentrations, lower efficacy in apoptosis induction was observed for Sb 2 O 3 than for As 2 O 3 .
Our special focus was set on substances that influence the glutathione redox state of the cell. Decrease of Ψ m was shown to play a crucial role in As 2 O 3 therapy-relevant effects [15, 17] . These effects are most probably based on inhibition of enzymes of the intracellular glutathione redox system, such as glutathione peroxidase GPx [57, 58] , glutathione reductase GR and glutathione-S-transferase [58] , resulting in an increase of ROS. In addition, a direct targeting of the mitochondrial permeability transition pore [59] was discussed as a possible mechanism. In this work, we were able to show enhancement of As 2 O 3 and Sb 2 O 3 effects by BSO, NaSal, NaAsc, MS and AT to different extents. As far as data on achievable and tolerable concentrations in vivo were available (BSO, NaSal, NaAsc), we have chosen concentrations within this range. Mainly BSO, an inhibitor of the rate limiting enzyme in glutathione (GSH)-synthesis γ-glutamylcystein synthetase [57, 60] -induced apoptosis by the caspase inhibitor Z-VAD-Fmk can be overcome by co-treatment of BSO. Therefore, this substance may be useful in treatment of malignancies in case of reduced sensitivity for apoptosis induction by agents affecting Ψ m or caspase activation.
Other known modulators of the glutathione redox system showed these effects to a lower extent and enhancement was not as consistent as with BSO, regarding the different cell lines treated. Nevertheless, the efficacy of enhancing As 2 O 3 -and Sb 2 O 3 -induced decrease of Ψ m not only by BSO but also to lower extend by MS and ascorbic acid could be shown in this report. Ascorbic acid [61] and MS [62] also were shown to enhance the effects of As 2 O 3 on mitochondria. In contradiction to our results, ascorbic acid was shown to protect from As 2 O 3 -induced toxicity [63] . However, evidence exists that ascorbic acid, widely praised as an antioxidant [64] , can act as an oxidizing agent in the presence of ROS-inducing substances [65, 66] . Recently, promising results of a phase I/II combined trial of As 2 O 3 and ascorbic acid were presented [47, [67] [68] [69] .
Overall, we were able to decipher the mechanism of Sb 2 O 3 -induced apoptosis and show that the basic mechanisms involved are the same as described for As 2 O 3 . We also have blocked three different enzymes involved in oxidative stress detoxification (catalase, γ-glutamylcystein synthetase, glutathione peroxidase) and shown that only BSO, the inhibitor of the γ-glutamylcystein synthetase, was highly synergistic with sub-apoptotic concentrations of As 2 O 3 or Sb 2 O 3 . The ability of specific drugs in clinically applicable concentrations to enhance the apoptotic effects of the two oxides in a synergistic way by may be helpful in reduction of their toxicity by the optimization of their doses. Moreover, further experiments may show how far our results on synergistic actions may be transferable for other combinations of drugs affecting the glutathione redox system and conventional cytostatic agents.
